换一批What is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis: switching to an IL-23 inhibitor or to another IL-17A inhibitor?
第一作者：
Yizhang,Liu
第一单位：
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China.;National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China.;Furong Laboratory, Changsha, China.;National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.;Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China.;Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China.;Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, China.
作者：
医学主题词
人类(Humans);银屑病(Psoriasis);白细胞介素17(Interleukin-17);女(雌)性(Female);男(雄)性(Male);回顾性研究(Retrospective Studies);中年人(Middle Aged);药物替代(Drug Substitution);成年人(Adult);治疗失败(Treatment Failure);白细胞介素23(Interleukin-23);皮肤科用药(Dermatologic Agents);疾病严重程度指数(Severity of Illness Index);抗体, 单克隆(Antibodies, Monoclonal);生活质量(Quality of Life)
DOI
10.1080/09546634.2025.2588072
PMID
41376531
发布时间
2025-12-11
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
